Biodiversity, chemical diversity and drug discovery.

Biodiversity, chemical diversity and drug discovery. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Biodiversity, chemical diversity and drug discovery. Abstract Text:

Sheo B Singh,Fernando Pelaez,Sheo B Singh,Fernando Pelaez,

Drugs developed from microbial natural products are in the fundaments of modern pharmaceutical companies. Despite decades of research, all evidences suggest that there must remain many interesting natural molecules with potential therapeutic application yet to be discovered. Any efforts to successfully exploit the chemical diversity of microbial secondary metabolites need to rely heavily on a good understanding of microbial diversity, being the working hypothesis that maximizing biological diversity is the key strategy to maximizing chemical diversity. This chapter presents an overview of diverse topics related with this basic principle, always in relation with the discovery of novel secondary metabolites. The types of microorganisms more frequently used for natural products discovery are briefly reviewed, as well as the differences between terrestrial and marine habitats as sources of bioactive secondary metabolite producers. The concepts about microbial diversity as applied to prokaryotes have evolved in the last years, but recent data suggest the existence of true biogeographic patterns of bacterial diversity, which are also discussed. Special attention is dedicated to the existing strategies to exploit the microbial diversity that is not easy to tackle by conventional approaches. This refers explicitly to the current attempts to isolate and cultivate the previously uncultured bacteria, including the application of high throughput techniques. Likewise, the advances of microbial molecular biology has allowed the development of metagenomic approaches, i.e., the expression of biosynthetic pathways directly obtained from environmental DNA and cloned in a suitable host, as another way of accessing microbial genetic resources. Also, approaches relying on the genomics of metabolite producers are reviewed.

Biodiversity, chemical diversity and drug discovery. Publishing Authors By Initials

SB Singh,F Pelaez,SB Singh,F Pelaez,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Biodiversity, chemical diversity and drug discovery. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Progress in drug research. Fortschritte der Arznei

VOLUME: 65

Page Numbers: 141, 143-74

Journal Abbreviation:

ISSN: 0071-786X

DAY: 18

MONTH: 12

YEAR: 2008

Biodiversity, chemical diversity and drug discovery. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 1304021

Biodiversity, chemical diversity and drug discovery. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Biodiversity, chemical diversity and drug discovery. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Biodiversity, chemical diversity and drug discovery.

AFFILIATION: Merck Research Laboratories, Rahway, New Jersey 07065, USA. Sheo_singh@merck.com

Country: Switzerland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Prog Drug Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Biodiversity, chemical diversity and drug discovery Related Publications

• Biodiversity, chemical diversity and drug discovery.
• Blood circulation laboratory investigations with video are less investigative than instructional blood circulation laboratories with live organisms.
• Enhancement of antibiotic and secondary metabolite detection from filamentous fungi by growth on nutritional arrays.
• Food-induced anaphylaxis caused by inhalation of soy protein.
• Insecticidal activity of caffeine aqueous solutions and caffeine oleate emulsions against Drosophila melanogaster and Hypothenemus hampei.
• Molecular phylogenetic studies show Omphalina giovanellae represents a new section of Clitopilus (Agaricomycetes).
• Scientific principles of education research: Experimental Biology 2007.
• [Medical statistics.]
• [The Archives of Clinical Histories of the Hospital Universitario "Gral. Calixto Garcia".]